Fitness & Wellness Business Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Fitness & Wellness Business Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Cytori Therapeutics
Cytori Enters Binding Letter of Intent for StemSource Cell Bank Sales for Singapore
August 20th, 2008
Cytori Therapeutics (NASDAQ:CYTX) entered into a Binding Letter of Intent to complete a StemSource(R) Cell Bank sales agreement with Astrea International. Astrea has committed to purchase one StemSource Cell Bank for Singapore following receipt of regulatory clearance in Singapore on a pending application on the use of the Celution(R) System for tissue banking. In addition, Astrea has obtained rights from Cytori to commercialize additional StemSource Cell Banks in Malaysia and Brunei. "The StemSource Cell Bank will allow patients in Singapore to affordably store their own stem and regenerative cells," said Dr. Ivan Puah of Astrea. "There is a significant opportunity to...
Source: Fitness & Wellness Business Week (2008-08-20)
|
